A hepatokine derived from the ER protein CREBH promotes triglyceride metabolism by stimulating lipoprotein lipase activity
Science Signaling · 17.01.2023 · 16 (768)
DOI: 10.1126/scisignal.add6702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, erschienen am 17.01.2023. Verfasst von Hyunbae Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI 48201, USA. Hauptthemen laut MEDLINE: Lipoprotein Lipase, Peptide Hormones, Cyclic AMP Response Element-Binding Protein. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
The endoplasmic reticulum (ER)–tethered, liver-enriched stress sensor CREBH is processed in response to increased energy demands or hepatic stress to release an amino-terminal fragment that functions as a transcription factor for hepatic genes encoding lipid and glucose metabolic factors. Here, we discovered that the carboxyl-terminal fragment of CREBH (CREBH-C) derived from membrane-bound, full-length CREBH was secreted as a hepatokine in response to fasting or hepatic stress. Phosphorylation of CREBH-C mediated by the kinase CaMKII was required for efficient secretion of CREBH-C through exocytosis. Lipoprotein lipase (LPL) mediates the lipolysis of circulating triglycerides for tissue uptake and is inhibited by a complex consisting of angiopoietin-like (ANGPTL) 3 and ANGPTL8. Secreted CREBH-C blocked the formation of ANGPTL3-ANGPTL8 complexes, leading to increased LPL activity in plasma and metabolic tissues in mice. CREBH-C administration promoted plasma triglyceride clearance and partitioning into peripheral tissues and mitigated hypertriglyceridemia and hepatic steatosis in mice fed a high-fat diet. Individuals with obesity had higher circulating amounts of CREBH-C than control individuals, and human CREBH loss-of-function variants were associated with dysregulated plasma triglycerides. These results identify a stress-induced, secreted protein fragment derived from CREBH that functions as a hepatokine to stimulate LPL activity and triglyceride homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI 48201, USA.
- Department of Biochemistry, Fraternal Order of Eagles Diabetes Research Center, and Obesity Research and Education Initiative, University of Iowa, Iowa City, IA 52242, USA.
- Department of Biochemistry, Microbiology and Immunology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
ORCID-Profile: Hyunbae Kim, Zhenfeng Song, Ren Zhang, Brandon S J Davies, Kezhong Zhang
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Kim, H., Song, Z., Zhang, R., Davies, B. S. J., & Zhang, K. (2023). A hepatokine derived from the ER protein CREBH promotes triglyceride metabolism by stimulating lipoprotein lipase activity. Science Signaling, 16(768). https://doi.org/10.1126/scisignal.add6702
Vancouver
Kim H, Song Z, Zhang R, Davies BSJ, Zhang K. A hepatokine derived from the ER protein CREBH promotes triglyceride metabolism by stimulating lipoprotein lipase activity. Science Signaling. 2023;16(768). doi:10.1126/scisignal.add6702
BibTeX
@article{Kim2023,
author = {Kim, Hyunbae and Song, Zhenfeng and Zhang, Ren and Davies, Brandon S J and Zhang, Kezhong},
title = {A hepatokine derived from the ER protein CREBH promotes triglyceride metabolism by stimulating lipoprotein lipase activity},
journal = {Science Signaling},
year = {2023},
volume = {16},
number = {768},
doi = {10.1126/scisignal.add6702}
}
EUVIMED